3 results match your criteria: "Medial University of Innsbruck[Affiliation]"
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
Thyroid
November 2024
Department of Nuclear Medicine, Medical University of Innsbruck, Austria.
Health economic appraisals often rely on the assessment of health utilities using preference-based measures (PBM). The cancer-specific PBM, European Organisation for Research and Treatment of Cancer Quality of Life Utility - Core 10 Dimensions (EORTC QLU-C10D), was developed recently, and now needs to be validated in various clinical populations. In a multicenter, multinational prospective cohort study, we longitudinally collected EORTC QLQ-C30 and EQ-5D-5L data from patients with thyroid cancer.
View Article and Find Full Text PDFPars interarticularis screws for posterior cervical fusion - investigating a new trajectory using a CT-based multiplanar reconstruction: Part I.
Acta Neurochir (Wien)
July 2024
Department of Neurosurgery, Medial University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Article Synopsis
- Lateral mass screw fixation is the standard for cervical fusion between C3 and C6 but can pose risks like nerve root and vertebral artery injuries, especially in traditional surgeries.
- This study introduces a new screw trajectory in the pars interarticularis region as a safer alternative for posterior cervical fusion and evaluates its effectiveness against existing methods.
- Results show that this new trajectory, especially Trajectory B, allows for longer screw placements with minimized risks to critical structures, making it a promising approach in minimally invasive spine surgery, pending further biomechanical validation.
Survival, Treatment Outcome, and Safety of Multiple and Repeated Courses of Stereotactic Body Radiotherapy for Pulmonary Oligometastases of Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
November 2023
Department of Radiation-Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Current literature regarding survival and treatment outcome of SBRT in patients with pulmonary oligometastatic head and neck squamous cell carcinoma (HNSCC) is limited. Additionally, most of the published studies include metastatic lesions deriving also from primaries with histologies other than SCC when investigating the outcome of SBRT. The aim of the present retrospective study is to explore local control (LC) of treated metastases, progression-free survival (PFS), and overall survival (OS) of exclusively pulmonary oligometastatic HNSCC-patients treated with SBRT.
View Article and Find Full Text PDF